This is further supported by the fact that omalizumab, a monoclonal antibody against IgE, is an effective treatment for ABPA [196], but A. fumigatus can also activate MCs in an IgE independent manner [197]. This evidence concerns the gene IGHE and allergic bronchopulmonary aspergillosis.